Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 625 of 3173 entries
View as:

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00976599 Org: User:
Start: 11/30/09 End: 07/31/11 Due: 07/31/12

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00130897 Org: User:
Start: 07/31/05 End: 11/30/11 Due: 11/30/12

A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)

Phase: N/A Priority: Normal
NCT ID: NCT01844804 Org: User:
Start: 05/31/13 End: 11/30/13 Due: 11/30/14

A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients

Phase: N/A Priority: Normal
NCT ID: NCT00971893 Org: User:
Start: 10/31/09 End: 04/30/10 Due: 04/30/11

Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02309827 Org: User:
Start: 12/31/14 End: 04/30/16 Due: 04/30/17

A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT06116591 Org: User:
Start: 11/08/23 End: 05/27/24 Due: 05/27/25

Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

Phase: N/A Priority: Normal
NCT ID: NCT01078298 Org: User:
Start: 03/31/10 End: 06/30/12 Due: 06/30/13

Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03974776 Org: User:
Start: 07/08/19 End: 01/10/20 Due: 01/10/21

Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01405196 Org: User:
Start: 12/31/11 End: 03/31/14 Due: 03/31/15

A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01531322 Org: User:
Start: 10/31/11 End: 01/31/12 Due: 01/31/13

Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

Phase: N/A Priority: Normal
NCT ID: NCT00572559 Org: User:
Start: 11/30/02 End: 01/31/05 Due: 01/31/06

Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00527397 Org: User:
Start: 08/31/07 End: 07/31/08 Due: 07/31/09

A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01893866 Org: User:
Start: 08/31/13 End: 10/31/13 Due: 10/31/14

A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06190561 Org: User:
Start: 01/15/24 End: 05/07/24 Due: 05/07/25

A Post Marketing Surveillance As Required By Philippine Food And Drug Administration

Phase: N/A Priority: Normal
NCT ID: NCT01781442 Org: User:
Start: 06/30/13 End: 06/30/15 Due: 06/30/16

Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05544786 Org: User:
Start: 09/28/22 End: 11/29/22 Due: 11/29/23

Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT00831532 Org: User:
Start: 02/28/09 End: 08/31/09 Due: 08/31/10

Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00998829 Org: User:
Start: 05/31/10 End: 05/31/12 Due: 05/31/13

A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT05512819 Org: User:
Start: 09/16/22 End: 02/12/26 Due: 02/12/27

Safety and Efficacy of Trastuzumab BS

Phase: N/A Priority: Normal
NCT ID: NCT04181333 Org: User:
Start: 08/09/23 End: 03/27/25 Due: 03/27/26

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT04657991 Org: User:
Start: 01/15/21 End: 12/30/25 Due: 12/30/26

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults

Phase: N/A Priority: Normal
NCT ID: NCT00644293 Org: User:
Start: 01/31/03 End: 04/30/04 Due: 04/30/05

Cost Effectiveness Of Linezolid In Central America

Phase: N/A Priority: Normal
NCT ID: NCT01040585 Org: User:
Start: 07/31/10 End: 03/31/11 Due: 03/31/12

A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Phase: N/A Priority: Normal
NCT ID: NCT05879718 Org: User:
Start: 07/07/23 End: 11/18/26 Due: 11/18/27

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Phase: N/A Priority: Normal
NCT ID: NCT05895786 Org: User:
Start: 05/20/23 End: 07/28/26 Due: 07/28/27